No abstract available
MeSH terms
-
Aldosterone / physiology
-
Biomarkers
-
Canrenone / chemistry
-
Canrenone / therapeutic use
-
Cause of Death
-
Double-Blind Method
-
Early Termination of Clinical Trials*
-
Eplerenone
-
Female
-
Heart Failure / drug therapy*
-
Heart Failure / mortality
-
Heart Failure / physiopathology
-
Hospitalization / statistics & numerical data
-
Humans
-
Hyperkalemia / chemically induced
-
Male
-
Mineralocorticoid Receptor Antagonists / adverse effects
-
Mineralocorticoid Receptor Antagonists / chemistry
-
Mineralocorticoid Receptor Antagonists / pharmacology
-
Mineralocorticoid Receptor Antagonists / therapeutic use*
-
Models, Cardiovascular
-
Molecular Structure
-
Multicenter Studies as Topic / methods
-
Multicenter Studies as Topic / statistics & numerical data*
-
Myocardial Infarction / complications
-
Patient Selection
-
Randomized Controlled Trials as Topic / methods
-
Randomized Controlled Trials as Topic / statistics & numerical data*
-
Renin-Angiotensin System / drug effects
-
Renin-Angiotensin System / physiology
-
Research Design*
-
Risk
-
Spironolactone / adverse effects
-
Spironolactone / analogs & derivatives*
-
Spironolactone / chemistry
-
Spironolactone / pharmacology
-
Spironolactone / therapeutic use
Substances
-
Biomarkers
-
Mineralocorticoid Receptor Antagonists
-
Spironolactone
-
Aldosterone
-
Eplerenone
-
Canrenone